Page last updated: 2024-09-05

alagebrium and Hypertension

alagebrium has been researched along with Hypertension in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desai, KM; Dhar, A; Dhar, I; Wu, L1
Chen, W; Cheng, X; Cui, H; He, K; Li, S; Wang, L; Zhang, B; Zhong, W1
Meyer, DM; Mills, LD; Mohammed, SF; Owan, TE; Redfield, MM; Schalkwijk, CG; Shapiro, BP1
Hartog, JW; Voors, AA; Willemsen, S1
Ahn, J; Frohlich, ED; Susic, D; Varagic, J1
Bakris, GL; Bank, AJ; Kass, DA; Neutel, JM; Oparil, S; Preston, RA1
Scuteri, A1
Capriotti, A; Clattenburg, L; Corretti, MC; Gerstenblith, G; Kass, DA; Melenovsky, V; Zieman, SJ1
Doggrell, SA1

Reviews

3 review(s) available for alagebrium and Hypertension

ArticleYear
Crosslink breakers: a new approach to cardiovascular therapy.
    Current opinion in cardiology, 2004, Volume: 19, Issue:4

    Topics: Aging; Animals; Blood Pressure; Cardiovascular Diseases; Collagen; Comorbidity; Cross-Linking Reagents; Diabetes Mellitus; Glycation End Products, Advanced; Humans; Hypertension; Kidney Failure, Chronic; Rats; Thiazoles; Treatment Outcome

2004
Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    American journal of hypertension, 2004, Volume: 17, Issue:12 Pt 2

    Topics: Aging; Animals; Blood Pressure; Blood Vessels; Cardiovascular Agents; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Glycation End Products, Advanced; Heart Failure; Humans; Hypertension; Thiazoles

2004
ALT-711 decreases cardiovascular stiffness and has potential in diabetes, hypertension and heart failure.
    Expert opinion on investigational drugs, 2001, Volume: 10, Issue:5

    Topics: Animals; Diabetes Mellitus; Heart Failure; Humans; Hypertension; Thiazoles

2001

Trials

1 trial(s) available for alagebrium and Hypertension

ArticleYear
Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension.
    Journal of hypertension, 2007, Volume: 25, Issue:3

    Topics: Aged; Aging; Blood Pressure; Carotid Arteries; Collagen; Elasticity; Endothelium, Vascular; Female; Glycation End Products, Advanced; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Manometry; Matrix Metalloproteinase 9; Middle Aged; Peripheral Vascular Diseases; Single-Blind Method; Thiazoles; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1; Vasodilation

2007

Other Studies

5 other study(ies) available for alagebrium and Hypertension

ArticleYear
Methylglyoxal, a reactive glucose metabolite, increases renin angiotensin aldosterone and blood pressure in male Sprague-Dawley rats.
    American journal of hypertension, 2014, Volume: 27, Issue:3

    Topics: Aldosterone; Angiotensins; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Catecholamines; Cells, Cultured; Disease Models, Animal; Hypertension; Male; NF-kappa B; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renin; Renin-Angiotensin System; RNA Interference; RNA, Messenger; Signal Transduction; Thiazoles; Time Factors; Up-Regulation

2014
Alagebrium (ALT-711) improves the anti-hypertensive efficacy of nifedipine in diabetic-hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:10

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Endothelin-1; Epoprostenol; Heart Rate; Hypertension; Male; Nifedipine; Nitric Oxide; Rats; Rats, Wistar; Thiazoles

2014
Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines.
    Circulation, 2008, Sep-02, Volume: 118, Issue:10

    Topics: Aging; Animals; Aorta; Collagen; Dogs; Drug Evaluation, Preclinical; Elastin; Glycation End Products, Advanced; Heart Ventricles; Hypertension; Lysine; Muscle, Smooth, Vascular; Thiazoles; Vasa Vasorum; Vascular Resistance; Ventricular Function, Left

2008
Letter by Hartog et al. regarding article, "Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines".
    Circulation, 2009, Mar-17, Volume: 119, Issue:10

    Topics: Animals; Arginine; Collagen; Cross-Linking Reagents; Dogs; Glycation End Products, Advanced; Hypertension; Lysine; Muscle, Smooth, Vascular; Thiazoles

2009
Slowing arterial aging: how far have we progressed?
    Journal of hypertension, 2007, Volume: 25, Issue:3

    Topics: Aging; Blood Pressure; Glycation End Products, Advanced; Humans; Hypertension; Peripheral Vascular Diseases; Thiazoles

2007